Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PRTO - Proteon Therapeutics Inc.

Previous close
0.8352
0   0%

Share volume: 0
Last Updated: Thu 09 Jan 2020 06:00:00 AM CET
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
$0.84
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 33%
Dept financing 5%
Liquidity 33%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.84
P/E Ratio 
N/A
DAY RANGE
N/A - N/A
EPS 
-$0.96
52 WEEK RANGE
$0.63 - $0.96
52 WEEK CHANGE
$0.00
MARKET CAP 
18.524 M
YIELD 
N/A
SHARES OUTSTANDING 
22.179 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$11,648,666
AVERAGE 10 VOLUME 
$3,926,483
AVERAGE 30 VOLUME 
$3,926,483
Company detail
CEO:
Region: US
Website: http://www.proteontherapeutics.com
Employees: 17
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.

Recent news